One Stop Shop for All Your Market Research Reports

Global Cholinesterase Inhibitors Sales Market Report 2021

Cholinesterase inhibitors (also called acetylcholinesterase inhibitors) are a group of medicines that block the normal breakdown of acetylcholine. Acetylcholine is the main neurotransmitter found in the body and has functions in both the peripheral nervous system and the central nervous system. For example, acetylcholine is released by motor neurons to activate muscles; acetylcholine also has an important role in arousal, attention, learning, memory and motivation. Cholinesterase inhibitors block the action of the enzyme cholinesterase, which is responsible for breaking down acetylcholine. This increases levels of acetylcholine in the synaptic cleft (the space between two nerve endings). The main use of cholinesterase inhibitors is for the treatment of dementia in patients with Alzheimer's disease. People with Alzheimer's disease have reduced levels of acetylcholine in the brain. Cholinesterase inhibitors have been shown to have a modest effect on dementia symptoms such as cognition. Market Analysis and Insights: Global Cholinesterase Inhibitors Market The global Cholinesterase Inhibitors market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Cholinesterase Inhibitors Scope and Market Size The global Cholinesterase Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cholinesterase Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type Haboyin Tacrine Donepezil Rivastigmine Galantamine Others Segment by Application Mild Patient Moderate Patient Serious Patient The Cholinesterase Inhibitors market is analysed and market size information is provided by regions (countries). Segment by Application, the Cholinesterase Inhibitors market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions. By Company Pfizer Shionogi Pharma Daiichi Pharmaceutical Co Ltd Novartis F. Hoffmann-La Roche Merck Eli Lily & Co Taloph pharmaceutical Forward group Eisai Co., Ltd ACI HealthCare Limited Actavis Elizabeth LLC Alembic pharms Ltd Aurobindo Cadila pharms Ltd Cipla Ltd CSPC Ouyi Dexcel pharma Dr.Reddy's Heritage Pharma Hetero Labs Ltd Indicus Pharma
1 Cholinesterase Inhibitors Market Overview 1.1 Cholinesterase Inhibitors Product Scope 1.2 Cholinesterase Inhibitors Segment by Type 1.2.1 Global Cholinesterase Inhibitors Sales by Type (2016 & 2021 & 2027) 1.2.2 Haboyin 1.2.3 Tacrine 1.2.4 Donepezil 1.2.5 Rivastigmine 1.2.6 Galantamine 1.2.7 Others 1.3 Cholinesterase Inhibitors
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 4000
Multi User US $6000
Corporate User US $8000
About this Report
Report ID 535572
Category
  • Pharmaceuticals and Healthcare
Published on 25-Oct
Number of Pages 145
Publisher Name QY Research
Editor Rating
★★★★★
★★★★★
(49)